EUVIMEDOpdag EUVIMED
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Multizentrische Studie

A Phase 3 Trial of Brepocitinib in Dermatomyositis

Ruth Ann Vleugels, Julie J Paik iD, Iazsmin Bauer Ventura, Aaron R Mangold, Prateek C Gandiga, Anna Haemel, Hector Chinoy, Yessar M Hussain, Kumaraswamy Sivakumar, Zoltan Griger, Eun Bong Lee, Francisca Bozan and 30 more

New England Journal of Medicine · 2026-05-14 · 394 (19) · 1883-1893

DOI: 10.1056/nejmoa2503531 ↗

At a glance

Randomisierte kontrollierte Studie in New England Journal of Medicine, published on 2026-05-14. Written by Ruth Ann Vleugels and 41 co-authors. Institution: Mass General Brigham Department of Dermatology, Harvard Medical School, Boston. Major MEDLINE topics: Dermatomyositis, Janus Kinase 1, Janus Kinase Inhibitors, TYK2 Kinase. Cited 26 times so far (Crossref); 24 references. Funded by: Priovant Therapeutics.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

MeSH terms (MEDLINE)

DermatomyositisJanus Kinase 1Janus Kinase InhibitorsTYK2 KinaseAdultAgedFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralDouble-Blind MethodDrug TaperingGlucocorticoidsSeverity of Illness IndexTreatment Outcome

Substances

GlucocorticoidsJanus Kinase 1Janus Kinase InhibitorsTYK2 Kinase

Authors and institutions

  • Mass General Brigham Department of Dermatology, Harvard Medical School, Boston.
  • Division of Rheumatology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore.
  • Division of Rheumatology, Department of Medicine, University of Chicago, Chicago.
  • Department of Dermatology, Mayo Clinic, Scottsdale, AZ.
  • Division of Rheumatology, Department of Medicine, Emory University, Atlanta.
  • Department of Dermatology, University of California, San Francisco, San Francisco.

ORCID profiles: Julie J Paik

Funding

  • Priovant Therapeutics

Cite

APA

Vleugels, R. A., Paik, J. J., Bauer Ventura, I., Mangold, A. R., Gandiga, P. C., Haemel, A., Chinoy, H., Hussain, Y. M., Sivakumar, K., Griger, Z., Lee, E. B., Bozan, F., Hsu, C. Y., Femia, A., Dimachkie, M. M., Min, M. S., Mozaffar, T., Charles-Schoeman, C., Fernandez, D. R., …, & VALOR Investigators (2026). A Phase 3 Trial of Brepocitinib in Dermatomyositis. New England Journal of Medicine, 394(19), 1883-1893. https://doi.org/10.1056/nejmoa2503531

Vancouver

Vleugels RA, Paik JJ, Bauer Ventura I, Mangold AR, Gandiga PC, Haemel A, et al. A Phase 3 Trial of Brepocitinib in Dermatomyositis. New England Journal of Medicine. 2026;394(19):1883-1893. doi:10.1056/nejmoa2503531

BibTeX
@article{Vleugels2026,
  author = {Vleugels, Ruth Ann and Paik, Julie J and Bauer Ventura, Iazsmin and Mangold, Aaron R and Gandiga, Prateek C and Haemel, Anna and Chinoy, Hector and Hussain, Yessar M and Sivakumar, Kumaraswamy and Griger, Zoltan and Lee, Eun Bong and Bozan, Francisca and Hsu, Chung-Yuan and Femia, Alisa and Dimachkie, Mazen M and Min, Michelle S and Mozaffar, Tahseen and Charles-Schoeman, Christina and Fernandez, David R and Onajin, Oluwakemi and Campanilho-Marques, Raquel and Marder, Galina and Ernste, Floranne and Schiopu, Elena and Sluzevich, Jason and Pearson, David and Lindsey, Stephen and Luggen, Michael and Bubb, Michael R and Boh, Erin and Maganti, Rashmi and Heinlen, Latisha and Shaw, Katharina S and Cascino, Matthew D and Mudd, Paul N and Vencovsky, Jiri and Fernandez, Anthony P and Fiorentino, David and Christopher-Stine, Lisa and Werth, Victoria P and Aggarwal, Rohit and VALOR Investigators, VALOR Investigators},
  title = {A Phase 3 Trial of Brepocitinib in Dermatomyositis},
  journal = {New England Journal of Medicine},
  year = {2026},
  volume = {394},
  number = {19},
  pages = {1883--1893},
  doi = {10.1056/nejmoa2503531}
}
Start for free →